Glow's business model pays off in its app
Written by Alyssa Clark
The problem of infertility and trouble conceiving a child is not only troubling for the females who are taking prenatal vitamins, exercising and eating the right foods, but the couples overall well-being is affected as well. The mHealth would wants to help those couples who seem plagued by the problem of infertility, by providing them with every resource possible in order to better their chances for a healthy conception.
Couples who are faced with the difficult problem of infertility or trouble conceiving can take refuge in knowing that a newly introduced app may hold some of the secrets in unlocking the path to conception. The App Store now holds the application entitled Glow which is an app proven to increase the chance of pregnancy. This company is so confident that they can get you pregnant, that they even offer to pay for infertility treatments if and when their system doesn’t work— confident to say the least. Glow is a program which is dependent upon the use of big data and the business sense of Pay Pal founder Max Levchin.
The idea for the Glow application came to its founders because they felt as if people who were trying to conceive did not have enough important information in order to know when their peak fertility was, and were becoming discouraged that they would never have children. Glow allows future parents and women more specifically, to track their period in order to understand their best windows for conception, and see if they need to be more active in their sex lives. The app is also useful because it can help future parents to stock up on ovulation kits and sending reminders to partners to avoid heat, in hopes of not killing any sperm.
Underneath the Glow First program, each couple spends $50 per month to use the app, and must try to conceive a child for at least 10 months while using the application. If using the program results in a pregnancy, then obviously the investment paid off. If not, the money from the community fund pays for infertility treatment. This business model is generating a wide-spread love of this product, and a renowned sense of community support.
About the Author
Alyssa Clark is the Editor of Healthcare Global